[go: up one dir, main page]

NO20024742L - Heterocykliske forbindelser, deres fremstilling og anvendelse - Google Patents

Heterocykliske forbindelser, deres fremstilling og anvendelse

Info

Publication number
NO20024742L
NO20024742L NO20024742A NO20024742A NO20024742L NO 20024742 L NO20024742 L NO 20024742L NO 20024742 A NO20024742 A NO 20024742A NO 20024742 A NO20024742 A NO 20024742A NO 20024742 L NO20024742 L NO 20024742L
Authority
NO
Norway
Prior art keywords
preparation
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
NO20024742A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024742D0 (no
Inventor
Akihiro Tasaka
Takenori Hitaka
Etsuya Matsutani
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO20024742D0 publication Critical patent/NO20024742D0/no
Publication of NO20024742L publication Critical patent/NO20024742L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20024742A 2000-04-07 2002-10-02 Heterocykliske forbindelser, deres fremstilling og anvendelse NO20024742L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000106836 2000-04-07
PCT/JP2001/002937 WO2001077107A1 (fr) 2000-04-07 2001-04-05 Production et utilisation de composes heterocycliques

Publications (2)

Publication Number Publication Date
NO20024742D0 NO20024742D0 (no) 2002-10-02
NO20024742L true NO20024742L (no) 2002-11-25

Family

ID=18619943

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024742A NO20024742L (no) 2000-04-07 2002-10-02 Heterocykliske forbindelser, deres fremstilling og anvendelse

Country Status (19)

Country Link
US (2) US6716863B2 (fr)
EP (1) EP1268473A1 (fr)
KR (1) KR20020028865A (fr)
CN (1) CN1444582A (fr)
AU (1) AU2001244726A1 (fr)
BR (1) BR0109851A (fr)
CA (1) CA2404760A1 (fr)
CO (1) CO5261589A1 (fr)
CZ (1) CZ20023264A3 (fr)
EE (1) EE200200576A (fr)
HU (1) HUP0300434A3 (fr)
IL (1) IL152115A0 (fr)
MX (1) MXPA02009621A (fr)
NO (1) NO20024742L (fr)
OA (1) OA12244A (fr)
PE (1) PE20011178A1 (fr)
PL (1) PL365787A1 (fr)
SK (1) SK14132002A3 (fr)
WO (1) WO2001077107A1 (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1136079A4 (fr) * 1998-10-08 2004-09-22 Takeda Chemical Industries Ltd Agents destines a retarder le passage d'un cancer hormono-dependant a un cancer hormono-independant
KR20050063747A (ko) * 2000-07-19 2005-06-28 다케다 야쿠힌 고교 가부시키가이샤 1-치환-1,2,3-트리아졸 유도체, 그 중간체, 및 이들의제조 방법
EP1382350A4 (fr) * 2001-04-25 2006-01-04 Takeda Pharmaceutical Remedes contre la recurrence postoperative du cancer du sein chez les femmes en premenopause
WO2002087619A1 (fr) * 2001-04-27 2002-11-07 Takeda Chemical Industries, Ltd. Methode de prevention et de traitement du cancer
US20040116330A1 (en) * 2001-04-27 2004-06-17 Kenichiro Naito Preventive/therapeutic method for cancer
JP2003137814A (ja) * 2001-08-10 2003-05-14 Takeda Chem Ind Ltd ＧｎＲＨアゴニストの併用剤
EP1439178A4 (fr) * 2001-10-05 2005-11-16 Takeda Pharmaceutical Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation
CA2466659A1 (fr) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Agents anticancer
AU2002349477A1 (en) * 2001-11-26 2003-06-10 Takeda Chemical Industries, Ltd. Bicyclic derivative, process for producing the same, and use
AU2003203170A1 (en) * 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
AU2003231098A1 (en) 2002-04-25 2003-11-10 University Of Connecticut Health Center Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
CN100339078C (zh) * 2002-12-16 2007-09-26 橘生药品工业株式会社 固体口服剂型药物
TW200505913A (en) * 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
TW200423931A (en) * 2003-04-30 2004-11-16 Hoffmann La Roche Novel aniline derivatives, their manufacture and use as pharmaceutical agents
US7247649B2 (en) * 2003-08-13 2007-07-24 Hoffmann-La Roche Inc. Oxazoles, their manufacture and use as pharmaceutical agents
US7259262B2 (en) 2003-10-24 2007-08-21 Hoffmann-La Roche Inc. Arylazole derivatives, their manufacture and use as pharmaceutical agents
US20050186275A1 (en) * 2004-02-23 2005-08-25 Standard Chem. & Pharm. Co. Ltd. Sustained release tamsulosin formulations
TW200612914A (en) 2004-03-05 2006-05-01 Hoffmann La Roche Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents
TW200531688A (en) 2004-03-05 2005-10-01 Hoffmann La Roche Novel pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
TW200533346A (en) * 2004-03-18 2005-10-16 Hoffmann La Roche Novel ether derivatives, their manufacture and use as pharmaceutical agents
US7179812B2 (en) 2004-04-02 2007-02-20 Hoffmann-La Roche Inc. Diazine derivatives
US7005526B2 (en) 2004-05-25 2006-02-28 Hoffmann-La Roche Inc. Thioether derivatives
US7163953B2 (en) 2004-05-25 2007-01-16 Hoffmann-La Roche Inc. Benzylether derivatives
US7618769B2 (en) * 2004-06-07 2009-11-17 Applied Materials, Inc. Textured chamber surface
US7288557B2 (en) 2004-09-21 2007-10-30 Hoffmann-La Roche Inc. Triazole derivatives
US7342030B2 (en) 2004-09-22 2008-03-11 Hoffmann-La Roche Inc. Indole derivatives
TW200626589A (en) * 2004-09-24 2006-08-01 Hoffmann La Roche Azole derivatives, their manufacture and use as pharmaceutical agents
US20060116407A1 (en) * 2004-11-22 2006-06-01 Birgit Bossenmaier Amide derivatives
TW200727900A (en) * 2005-07-27 2007-08-01 Yakult Honsha Kk Aqueous solution preparation containing camptothecins
TW200738680A (en) * 2005-08-04 2007-10-16 Hoffmann La Roche Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
EP1915370A1 (fr) * 2005-08-08 2008-04-30 F.Hoffmann-La Roche Ag Derives de pyrazole, leur fabrication et leur utilisation comme agents pharmaceutiques
EP1934210A1 (fr) * 2005-09-30 2008-06-25 F.Hoffmann-La Roche Ag Dérivés de diazine azole, leur fabrication et leur utilisation en tant qu agents pharmaceutiques
WO2008034579A1 (fr) * 2006-09-20 2008-03-27 F. Hoffmann-La Roche Ag Derives de 2-heterocyclyl-5-phenoxymethylpyridine utilises en tant qu'agents anticancereux
KR20090090336A (ko) 2006-12-12 2009-08-25 다케다 야쿠힌 고교 가부시키가이샤 융합된 헤테로시클릭 화합물
US9101617B2 (en) 2007-04-20 2015-08-11 Daido Chemical Corporation Base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion
PE20091580A1 (es) 2008-03-12 2009-11-05 Takeda Pharmaceutical Compuesto heterociclico fusionado
TW201016704A (en) * 2008-09-26 2010-05-01 Takeda Pharmaceutical Prevention and treatment of cancer with RAS gene mutation
TW201016703A (en) * 2008-09-26 2010-05-01 Takeda Pharmaceutical Prevention and treatment of cancer with LKB1 non-expression (deletion or mutation)
EP2484383B1 (fr) 2009-09-30 2021-04-28 Kabushiki Kaisha Sangi Procédé permettant d'améliorer la solubilité aqueuse de substances médiocrement solubles
US8900628B2 (en) 2010-02-26 2014-12-02 Nisshin Kasei Co., Ltd. Hard capsule and method for producing same
WO2011153050A1 (fr) 2010-06-02 2011-12-08 The Trustees Of The University Of Pennsylvania Méthodes et utilisation de composés qui se lient au complexe du récepteur her2/neu
US8993634B2 (en) 2010-06-02 2015-03-31 The Trustees Of The University Of Pennsylvania Methods and use of compounds that bind to Her2/neu receptor complex
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
US9364438B2 (en) 2012-09-26 2016-06-14 Takeda Pharmaceutical Company Limited Process for producing solid particles
US9468681B2 (en) 2013-03-01 2016-10-18 California Institute Of Technology Targeted nanoparticles
ES2882255T3 (es) 2015-07-01 2021-12-01 California Inst Of Techn Sistemas de administración basados en polímeros de ácido múcico catiónicos
EP3238711B1 (fr) 2016-04-26 2023-07-12 Mitsubishi Chemical Corporation Base pour dispersion solide, procédé de production d'une dispersion solide l'utilisant et dispersion solide
CA2995617A1 (fr) * 2017-11-03 2019-05-03 Universite De Montreal Inhibiteurs d'activite mitochondrique heterocycliques et utilisations associees
CA3099440A1 (fr) 2018-06-13 2019-12-19 California Institute Of Technology Nanoparticules permettant de traverser la barriere hematoencephalique et methodes de traitement faisant appel a celle-ci
AU2019407426A1 (en) 2018-12-21 2021-07-22 Daiichi Sankyo Company, Limited Combination of antibody-drug conjugate and kinase inhibitor
WO2021118924A2 (fr) 2019-12-12 2021-06-17 Ting Therapeutics Llc Compositions et méthodes de prévention et de traitement de la perte d'audition
CN114217025B (zh) * 2021-12-17 2024-01-23 哈尔滨工业大学 评估空气质量浓度预测中气象数据对其影响的分析方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05506857A (ja) 1990-04-16 1993-10-07 ローヌ―プーラン　ローラー　インターナショナル　（ホウルディングス）インコーポレイテッド Ｅｇｆレセプタチロシンキナーゼを阻害するスチリル―置換単環式および二環式複素アリール化合物
KR20000065227A (ko) * 1996-07-19 2000-11-06 다께다 구니오 복소환 화합물, 그의 제조방법 및 용도

Also Published As

Publication number Publication date
NO20024742D0 (no) 2002-10-02
AU2001244726A1 (en) 2001-10-23
CZ20023264A3 (cs) 2003-02-12
IL152115A0 (en) 2003-05-29
HUP0300434A3 (en) 2004-11-29
WO2001077107A8 (fr) 2003-02-13
US20020173526A1 (en) 2002-11-21
KR20020028865A (ko) 2002-04-17
HUP0300434A2 (hu) 2003-06-28
OA12244A (en) 2006-05-10
CO5261589A1 (es) 2003-03-31
MXPA02009621A (es) 2003-05-14
EE200200576A (et) 2004-06-15
CA2404760A1 (fr) 2001-10-18
CN1444582A (zh) 2003-09-24
US6716863B2 (en) 2004-04-06
WO2001077107A1 (fr) 2001-10-18
EP1268473A1 (fr) 2003-01-02
BR0109851A (pt) 2003-06-03
PE20011178A1 (es) 2001-11-19
PL365787A1 (en) 2005-01-10
SK14132002A3 (sk) 2003-04-01
WO2001077107B1 (fr) 2001-12-20
US20040024035A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
NO20015362D0 (no) Heterocyklisk substituerte benzimidazoler, deres fremstilling og anvendelse derav
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
NO20011956L (no) Substituerte fenylderivater, deres fremstilling og anvendelse
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1246802T3 (da) 4-aminopicolinater og deres anvendelse som herbicider
NO20030596D0 (no) Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
NO20011436D0 (no) 2,2,6,6-dietyl-dimetyl-1-alkoksy-piperidin-forbindelser og deres korresponderende 1-oksider
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20032234D0 (no) Nye imidazolderivater, deres fremstilling og anvendelse
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
NO20024105L (no) Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO996156L (no) Substituerte cykloheptener, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application